MoonLake posts Phase 2 results for sonelokimab in psoriatic arthritis and hidradenitis suppurativaSep 10Weekly roundup, 2 itemsMoonLake Immunotherapeutics AGsonelokimab
MoonLake reports positive Phase 3 IZAR-1 results in psoriatic arthritis, Q2 2026 earningsAug 10Quarterly updateMoonLake Immunotherapeutics AGsonelokimab
Sign inSign in